Skip to content

Saliva may have infectious amounts of HCV in presence of high HCV viral load and gum disease

Peg-IFN achieves poor results in HIV-HCV patients even when used with ribavirin

Should treatment breaks be guided by CD4? Study suggests yes

South Africa: MCC back pedals on nevirapine for mums to be

HIV-positive Brazilian women find adherence hard

Tenofovir no more likely than d4T to cause kidney side-effects

Use drug holidays cautiously in NNRTI-treated patients

Starting HAART at higher CD4 cell counts means treatment can be safely stopped for longer

15% of patients who fail treatment with NRTI, NNRTIs and PIs die within 3 years